Lcc Technologies Limited
Research and experimental development on biotechnology · Cheshire
ActiveUnited KingdomIncorporated 2025Private Limited Company
Financial position
Accounts to 2025-12-31 · GBP · Company accounts
Net assets
−£1,129,899
Cash
£249,290
Turnover
—
Profit / loss
−£1,129,999
Current assets
£1,240,271
Creditors < 1 year
£2,712,316
Equity
−£1,129,899
Average employees
18
Balance-sheet trend
GBP · companyTwo periods with a known, matching scope are needed for a trend.
Financial statements
Selected figures from the best-ranked available filing for each period. Missing values remain unknown.
| Reported figures | 2025-12-31Company |
|---|---|
| Balance sheet | |
| Net assets | −£1,129,899 |
| Equity | −£1,129,899 |
| Assets | |
| Fixed assets | £342,146 |
| Intangible assets | £23,954 |
| Property, plant & equipment | £318,192 |
| Current assets | £1,240,271 |
| Cash at bank | £249,290 |
| Stock | £689,755 |
| Liabilities | |
| Creditors within one year | £2,712,316 |
| Net current assets | −£1,472,045 |
| Assets less current liabilities | −£1,129,899 |
| Profit & loss | |
| Profit / loss | −£1,129,999 |
| People & pay | |
| Average employees | 18 |
| Source evidence | View filing |
Secured borrowing
Registered charges, lenders and security interests.
Charges and related records
0 outstanding chargesPhoenix signals
Companies sharing directors across a closure — possible restarts
Lcc Therapeutics Ltd.
48%formed sharing 1 director with this insolvent company · 15 days apart · 66% name match
No charges available in our records.